Synopsis
Synopsis
0
EU WC
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Epilincomycin
2. Hemihydrate Lincomycin Monohydrochloride
3. Lincocin
4. Lincolnensin
5. Lincomycin
6. Lincomycin A
7. Lincomycin Monohydrochloride
8. Lincomycin Monohydrochloride, (2s-cis)-isomer
9. Lincomycin Monohydrochloride, (l-threo)-isomer
10. Lincomycin Monohydrochloride, Hemihydrate
11. Lincomycin, (2s-cis)-isomer
12. Lincomycin, (l-threo)-isomer
1. 859-18-7
2. Lincomycin Hcl
3. Frademicina
4. Lincomycin (hydrochloride)
5. Mycivin
6. Lincomycin Hydrochloride Anhydrous
7. Nsc 70731
8. Lincocin
9. Gcw8y9936l
10. Lincomix 20
11. Pura Ject 100
12. Ncgc00159326-02
13. Lincolnensin, Hydrochloride
14. Dsstox_cid_27780
15. Dsstox_rid_82556
16. Dsstox_gsid_47803
17. (2s,4r)-n-((1r,2r)-2-hydroxy-1-((2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2h-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide Hydrochloride
18. Lincolnensin Hydrochloride
19. Antibiotic 124a, Hydrochloride
20. Lincogap
21. U 10149a
22. Lincocin Hydrochloride
23. Unii-gcw8y9936l
24. Mfcd00083647
25. Einecs 212-726-7
26. Cas-859-18-7
27. Lincomycin Hcl (lincocin)
28. Ec 212-726-7
29. Schembl192964
30. Chembl1201097
31. Dtxsid7047803
32. Hy-b0417a
33. Lincocin Hydrochloride Monohydrate
34. Tox21_111575
35. Akos024375415
36. Tox21_111575_1
37. Ccg-220302
38. Anhydrous Lincomycin Hydrochloride
39. Lincomycin Hydrochloride [who-dd]
40. Ncgc00159326-03
41. As-13720
42. Lincomycin Hydrochloride, >=90% (tlc)
43. Lincomycin Hydrochloride, >=95.0% (tlc)
44. L0166
45. Lincomycin Hydrochloride Anhdrous [mi]
46. Lincomycin Hydrochloride For System Suitability
47. 859l187
48. A841491
49. Anhydrous Lincomycin Hydrochloride [mart.]
50. Q27279041
51. Lincomycin Hydrochloride, Bioreagent, Suitable For Cell Culture
52. Lincomycin Hydrochloride, British Pharmacopoeia (bp) Reference Standard
53. (2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboximidic Acid Hydrochloride
54. (2s-trans)-methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-d-erythro-.alpha.-d-galacto-octopyranoside Hydrochloride
55. D-erythro-.alpha.-d-galacto-octopyranoside, Methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, Monohydrochloride, (2s-trans)-
56. D-erythro-.alpha.-d-galacto-octopyranoside, Methyl 6,8-dideoxy-6-[[[(2s,4r)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, Hydrochloride (1:1)
57. D-erythro-alpha-d-galacto-octopyranoside, Methyl 6,8-dideoxy-6-((((2s,4r)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, Monohydrochloride
58. D-erythro-alpha-d-galacto-octopyranoside, Methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, Monohydrochloride, (2s-trans)-
59. D-erythro-d-galacto-octopyranoside, Methyl 6,8-dideoxy-6-(1-methyl-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-, Monohydrochloride, Trans-alpha-
60. Hydron; N-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl)propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide; Chloride;(2s,4r)-n-{(1s)-2-hydroxy-1-[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2h-2-pyranyl]propyl}-1-methyl-4-propylpyrrolidine-2-carboxamide Hydrochloride
61. Methyl (2s-trans)-6,8-dideoxy-6-(((1-methyl-4-propylpyrrolidin-2-yl)carbonyl)amino)-1-thio-d-erythro-alpha-d-galacto-octopyranoside Monohydrochloride
62. Methyl 6,8-dideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-d-erythro-.alpha.-d-galacto-octopyranoside Monohydrochloride
Molecular Weight | 443.0 g/mol |
---|---|
Molecular Formula | C18H35ClN2O6S |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 7 |
Exact Mass | 442.1904357 g/mol |
Monoisotopic Mass | 442.1904357 g/mol |
Topological Polar Surface Area | 148 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 499 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Lincocin |
PubMed Health | Lincomycin (Oral route, Injection route) |
Drug Classes | Antibiotic, Lincosamide |
Drug Label | LINCOCIN Sterile Solution contains lincomycin hydrochloride which is the monohydrated salt of lincomycin, a substance produced by the growth of a member of the lincolnensis group of Streptomyces lincolnensis (Fam. Streptomycetaceae). The chemical nam... |
Active Ingredient | Lincomycin hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 300mg base/ml |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
2 of 2 | |
---|---|
Drug Name | Lincocin |
PubMed Health | Lincomycin (Oral route, Injection route) |
Drug Classes | Antibiotic, Lincosamide |
Drug Label | LINCOCIN Sterile Solution contains lincomycin hydrochloride which is the monohydrated salt of lincomycin, a substance produced by the growth of a member of the lincolnensis group of Streptomyces lincolnensis (Fam. Streptomycetaceae). The chemical nam... |
Active Ingredient | Lincomycin hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 300mg base/ml |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
Protein Synthesis Inhibitors
Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
VMF Number : 6222
Submission : 2018-01-19
Status : Active
Type : II
VMF Number : 6499
Submission : 2022-12-14
Status : Active
Type : II
VMF Number : 5819
Submission : 2004-09-09
Status : Active
Type : II
VMF Number : 6212
Submission : 2017-12-07
Status : Active
Type : II
VMF Number : 5939
Submission : 2008-11-28
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?